Eleni Kafkia

Eleni Kafkia

Auto-generated profile, based on publicly available information

Eleni Kafkia

European Molecular Biology Laboratory (EMBL), Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Cell Systems
Verified
Journal Article
Open access
OPOlga Ponomarova
Olga Ponomarova
NGNatalia Gabrielli
Natalia Gabrielli
DSDaniel C. Sévin
Daniel C. Sévin
MMMichael Mülleder
Michael Mülleder
KZKatharina Zirngibl
Katharina Zirngibl
KPKiran Raosaheb Patil
Kiran Raosaheb Patil
Many microorganisms live in communities and depend on metabolites secreted by fellow community members for survival. Yet our knowledge of interspecies metabolic dependencies is limited to few communities with small number of exchanged metabolites, and even less is known about cellular regulation facilitating metabolic exchange. Here we show how yeast enables growth of lactic acid bacteria through endogenous, multi-component, cross-feeding in a readily established community. In nitrogen-rich environments, Saccharomyces cerevisiae adjusts its metabolism by secreting a pool of metabolites, especially amino acids, and thereby enables survival of Lactobacillus plantarum and Lactococcus lactis. Quantity of the available nitrogen sources and the status of nitrogen catabolite repression pathways jointly modulate this niche creation. We demonstrate how nitrogen overflow by yeast benefits L. plantarum in grape juice, and contributes to emergence of mutualism with L. lactis in a medium with lactose. Our results illustrate how metabolic decisions of an individual species can benefit others.

8 September 2021 in Nature
Verified
Journal Article
Closed access
PDF file
MKMartina Klünemann
Martina Klünemann
SASergej Andrejev
Sergej Andrejev
SBSonja Blasche
Sonja Blasche
AMAndre Mateus
Andre Mateus
Prasad PhapalePrasad Phapale
Prasad Phapale
KPKiran R. Patil
Kiran R. Patil

4 January 2021 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
SBSonja Blasche
Sonja Blasche
YKYongkyu Kim
Yongkyu Kim
RMRuben A. T. Mars
Ruben A. T. Mars
DMDaniel Machado
Daniel Machado
MMMaria Maansson
Maria Maansson
KPKiran Raosaheb Patil
Kiran Raosaheb Patil

15 May 2017 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KHKristina Havas
Kristina Havas
VMVladislava Milchevskaya
Vladislava Milchevskaya
KRKsenija Radic
Ksenija Radic
AAAshna Alladin
Ashna Alladin
EKEleni Kafkia
Eleni Kafkia
MJMartin Jechlinger
Martin Jechlinger
Tumor recurrence is the leading cause of breast cancer–related death. Recurrences are largely driven by cancer cells that survive therapeutic intervention. This poorly understood population is referred to as minimal residual disease. Here, using mouse models that faithfully recapitulate human disease together with organoid cultures, we have demonstrated that residual cells acquire a transcriptionally distinct state from normal epithelium and primary tumors. Gene expression changes and functional characterization revealed altered lipid metabolism and elevated ROS as hallmarks of the cells that survive tumor regression. These residual cells exhibited increased oxidative DNA damage, potentiating the acquisition of somatic mutations during hormonal-induced expansion of the mammary cell population. Inhibition of either cellular fatty acid synthesis or fatty acid transport into mitochondria reduced cellular ROS levels and DNA damage, linking these features to lipid metabolism. Direct perturbation of these hallmarks in vivo, either by scavenging ROS or by halting the cyclic mammary cell population expansion, attenuated tumor recurrence. Finally, these observations were mirrored in transcriptomic and histological signatures of residual cancer cells from neoadjuvant-treated breast cancer patients. These results highlight the potential of lipid metabolism and ROS as therapeutic targets for reducing tumor recurrence in breast cancer patients.

2 September 2022 in Science Advances
Verified
Journal Article
Open access
EKEleni Kafkia
Eleni Kafkia
AAAmparo Andres-Pons
Amparo Andres-Pons
KGKerstin Ganter
Kerstin Ganter
MSMarkus Seiler
Markus Seiler
TSTom S. Smith
Tom S. Smith
KPKiran Raosaheb Patil
Kiran Raosaheb Patil
Nucleic acid and histone modifications critically depend on the tricarboxylic acid (TCA) cycle for substrates and cofactors. Although a few TCA cycle enzymes have been reported in the nucleus, the corresponding pathways are considered to operate in mitochondria. Here, we show that a part of the TCA cycle is operational also in the nucleus. Using13C-tracer analysis, we identified activity of glutamine-to-fumarate, citrate-to-succinate, and glutamine-to-aspartate routes in the nuclei ofHeLacells. Proximity labeling mass spectrometry revealed a spatial vicinity of the involved enzymes with core nuclear proteins. We further show nuclear localization of aconitase 2 and 2-oxoglutarate dehydrogenase in mouse embryonic stem cells. Nuclear localization of the latter enzyme, which produces succinyl-CoA, changed from pluripotency to a differentiated state with accompanying changes in the nuclear protein succinylation. Together, our results demonstrate operation of an extended metabolic pathway in the nucleus, warranting a revision of the canonical view on metabolic compartmentalization.

1 August 2021 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
DKDimitrios Konstantinidis
Dimitrios Konstantinidis
FPFilipa Pereira
Filipa Pereira
EGEva‐Maria Geissen
Eva‐Maria Geissen
KGKristina Grkovska
Kristina Grkovska
EKEleni Kafkia
Eleni Kafkia
KPKiran Raosaheb Patil
Kiran Raosaheb Patil
Adaptive laboratory evolution has proven highly effective for obtaining microorganisms with enhanced capabilities. Yet, this method is inherently restricted to the traits that are positively linked to cell fitness, such as nutrient utilization. Here, we introduce coevolution of obligatory mutualistic communities for improving secretion of fitness‐costly metabolites through natural selection. In this strategy, metabolic cross‐feeding connects secretion of the target metabolite, despite its cost to the secretor, to the survival and proliferation of the entire community. We thus co‐evolved wild‐type lactic acid bacteria and engineered auxotrophic Saccharomyces cerevisiae in a synthetic growth medium leading to bacterial isolates with enhanced secretion of two B‐group vitamins, viz., riboflavin and folate. The increased production was specific to the targeted vitamin, and evident also in milk, a more complex nutrient environment that naturally contains vitamins. Genomic, proteomic and metabolomic analyses of the evolved lactic acid bacteria, in combination with flux balance analysis, showed altered metabolic regulation towards increased supply of the vitamin precursors. Together, our findings demonstrate how microbial metabolism adapts to mutualistic lifestyle through enhanced metabolite exchange.